This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wang, X.-S. Articles by Chen, W.-F. Search for Related Content PubMed PubMed Citation Articles by Wang, X.-S. Articles by Chen, W.-F.

Rapid Identification of UCA1 as a Very Sensitive and Specific Unique Marker for Human Bladder Carcinoma

Authors' Affiliations: ¹ Department of Urology, First Hospital of Peking University, Institute of Urology, Peking University and ² Department of Immunology, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China

Requests for reprints: Wei-Feng Chen, Department of Immunology, Peking University Health Science Center, Central Research Building 611, 38 Xueyuan Road, Beijing, China 100083. Phone: 86-10-8280-2593; Fax: 86-10-8280-1436; E-mail: wfchen{at}bjmu.edu.cn

Purpose: The most common genitourinary malignancy in China is bladder transitional cell carcinoma (TCC). Early diagnosis of new and recurrent bladder cancers, followed by timely treatment, will help decrease mortality. There are currently no satisfactory markers for bladder cancer available in clinics. Better diagnostic methods are highly demanded.

Experimental Design: In this research, we have used comprehensive expressed sequence tag analysis, serial analysis of gene expression, and microarray analysis and quickly discovered a candidate marker, urothelial carcinoma associated 1 (UCA1). The UCA1 gene was characterized and its performance as a urine marker was analyzed by reverse transcription-PCR with urine sediments. A total of 212 individuals were included in this study, 94 having bladder cancers, 33 ureter/pelvic cancers, and 85 normal and other urinary tract disease controls.

Results: UCA1 was identified as a novel noncoding RNA gene dramatically up-regulated in TCC and it is the most TCC-specific gene yet identified. The full-length cDNA was 1,439 bp, and sequence analysis showed that it belonged to the human endogenous retrovirus H family. Clinical tests showed that UCA1 assay was highly specific (91.8%, 78 of 85) and very sensitive (80.9%, 76 of 94) in the diagnosis of bladder cancer and was especially valuable for superficial G2-G3 patients (sensitivity 91.1%, 41 of 45). It showed excellent differential diagnostic performance in various urinary tract diseases without TCC.

Conclusions: UCA1 is a very sensitive and specific unique marker for bladder cancer. It could have important implications in postoperative noninvasive follow-up. This research also highlights a shortcut to new cancer diagnostic assays through integration of in silico isolation methods with translational clinical tests based on RNA detection protocols.

This article has been cited by other articles:

				M. Hanke, I. Kausch, G. Dahmen, D. Jocham, and J. M. Warnecke Detailed Technical Analysis of Urine RNA-Based Tumor Diagnostics Reveals ETS2/Urokinase Plasminogen Activator to Be a Novel Marker for Bladder Cancer Clin. Chem., December 1, 2007; 53(12): 2070 - 2077. [Abstract] [Full Text] [PDF]

				W. P. Tsang, T. W.L. Wong, A. H.H. Cheung, C. N.N. Co, and T. T. Kwok Induction of drug resistance and transformation in human cancer cells by the noncoding RNA CUDR RNA, June 1, 2007; 13(6): 890 - 898. [Abstract] [Full Text] [PDF]